Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.
about
PARL Leu262Val is not associated with fasting insulin levels in UK populationsCandidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin actionA major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican AmericansPlasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and womenEpidemiological and clinical studies on insulin resistance and diabetes.Assessment of the effects of insulin secretagogues in humans.Significant association of insulin and proinsulin with clustering of cardiovascular risk factors.Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn sizeIncrease in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study.Raised proinsulin concentration as early indicator of beta cell dysfunction.Fetal and infant growth and impaired glucose tolerance at age 64.An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remissionQuantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7.Characterisation of morbidity in a UK, hospital based, obesity clinic.Measurement of insulin secretion in type 2 diabetes: problems and pitfalls.Sex differences in HDL ApoC-III in American Indian youth.Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study.Prenatal and Childhood Growth, Chemerin Concentrations, and Metabolic Health in Adult Life.Difficulties in localization and treatment of insulinomas in type 1 multiple endocrine adenomatosis (MEA).Triglycerides and disease.Use of specific immunoradiometric assay to determine preterm neonatal insulin-glucose relations.Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humansAbnormal cation exchange in insulin-resistant patients with essential hypertension.Effects of octreotide on circulating islet B cell products in endogenous hyperinsulinism.Shortness at birth is associated with insulin resistance in pre-pubertal Jamaican children.Effects of changes in acid base and calcium concentration on fasting serum insulin, proinsulin, and glucose concentrations.Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis.The genetics and pathophysiology of type II and gestational diabetes.Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.Maternal weight in pregnancy and offspring body composition in late adulthood: findings from the Helsinki Birth Cohort Study (HBCS).Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications.Fetal growth and glucose and insulin metabolism in four-year-old Indian children.Kinetic analysis of the type-1 proinsulin endopeptidase by a monoclonal antibody-based immunoadsorbent assay.A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase.The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.Birth weight and the metabolic syndrome: thrifty phenotype or thrifty genotype?Co-secretion of carboxypeptidase H and insulin from isolated rat islets of Langerhans.Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.
P2860
Q24655381-62CFFEAD-AEFF-4C06-90BE-DAA5C57E328BQ24803901-9732A7A9-C5F7-47C0-8516-C48522DD086DQ28361785-DB927152-5C50-4FDB-AB48-BFACF66B0333Q33612425-7855E8C3-F888-42DC-BF76-BDBF01BF7533Q33942488-ED1C3C8F-E608-488E-8F9B-0AEEB3E0E8C6Q34091890-391FA555-607B-46DA-BAC2-451EFD12A1FFQ34166369-97306959-0FF8-4ED7-A3F9-B46F8C7906CCQ34382453-E8CFD866-E1B1-4F8A-9F22-5EBB1821544AQ34545496-66A3AB3C-975A-495D-8BA1-59CEEE058D4CQ34588512-A5F1BB2D-666D-4C2B-9D70-1B2A5F813AD4Q34874543-82ECE767-9D3D-4113-9455-F827A9982906Q35180412-F85C6EF8-E890-40A9-88C3-72591886CB7DQ35181794-8CE3FBB4-96E8-4CFD-BF7C-1549F5FA0702Q35295001-7C511883-991E-453F-99F4-35654B3A2B9DQ35882347-E73B0ABE-C205-472A-85AE-3CE9C2727E7DQ36152839-FD92CF2A-9E23-4943-87F3-536D761CA0B8Q36378008-69F15D0A-8309-46A5-BD81-FC17A40C4EE4Q36478598-A7D1D5B4-59E7-4EF6-A536-99AB6F9E8625Q36538004-71CDBC5D-0B28-4788-B96E-460B6FA3461BQ36556302-7AF80B8E-D1A1-44C8-A83C-0BAB9B4D3F46Q36682496-A9A52BAD-359A-400F-B33E-953F67CED087Q36683565-15C4A8EE-A1D2-4DEE-ABD1-EC6C01E15567Q36860097-7549874B-1480-4F6E-8375-BB610A20081EQ37350440-5111D919-B35A-4BB3-AF9D-262915DD82D3Q37683744-FC894D7D-9175-43C2-AE2C-8C80525A0B3BQ38661282-2E7C6115-3C5E-4B30-9EE5-140454892E5DQ38903960-3A78C10D-F430-4456-BEBE-380E8E4EA72BQ39659512-66765F09-2603-4EBF-B99E-9C3CB5070F56Q40443083-32BDA431-B5DA-4329-80CC-6CACF8B1D48EQ40945389-82B151E9-1623-458E-B155-232FB1898C02Q40993285-CE8ED626-DF68-42FC-AABE-92C6155655C4Q41181288-0417849F-0C5A-443C-9E24-0B48BECA2C62Q41457652-AF0B00F2-ECF9-4EE9-800E-C3F49EB00F7BQ41674274-983AFE59-EA60-4808-8949-1250D427FDDFQ41838707-D8E9C64C-7E8D-4239-BCFC-13D9E59E0DE3Q41841111-65B9767C-AFCF-4190-B85B-DDE8F4A2A1FFQ42481343-48761E79-232C-4F4A-83EE-8B0B31F92192Q42623383-7E9AA2DB-B9B8-4EAD-94A3-B801A75FB130Q42804937-3077882D-12CA-421C-A642-DFA7C065E08FQ43185085-F1CB1A53-A8E1-4295-90D3-F33E77481019
P2860
Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@en
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@nl
type
label
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@en
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@nl
prefLabel
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@en
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@nl
P2093
P2860
P356
P1433
P1476
Sensitive and specific two-sit ...... t and 32-33 split proinsulins.
@en
P2093
A E Schneider
C A Carrington
P2860
P304
P356
10.1042/BJ2600535
P407
P577
1989-06-01T00:00:00Z